Cargando…
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266348/ https://www.ncbi.nlm.nih.gov/pubmed/28081595 http://dx.doi.org/10.3350/cmh.2016.0108 |
| _version_ | 1782500452282138624 |
|---|---|
| author | Song, Byung-Cheol |
| author_facet | Song, Byung-Cheol |
| author_sort | Song, Byung-Cheol |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5266348 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | The Korean Association for the Study of the Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52663482017-01-26 Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? Song, Byung-Cheol Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2016-12 2016-12-25 /pmc/articles/PMC5266348/ /pubmed/28081595 http://dx.doi.org/10.3350/cmh.2016.0108 Text en Copyright © 2016 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Song, Byung-Cheol Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? |
| title | Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? |
| title_full | Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? |
| title_fullStr | Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? |
| title_full_unstemmed | Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? |
| title_short | Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination? |
| title_sort | switch to tenofovir-based therapy or to continue adefovir-based therapy in chb patients with suboptimal response to adefovir-based combination? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266348/ https://www.ncbi.nlm.nih.gov/pubmed/28081595 http://dx.doi.org/10.3350/cmh.2016.0108 |
| work_keys_str_mv | AT songbyungcheol switchtotenofovirbasedtherapyortocontinueadefovirbasedtherapyinchbpatientswithsuboptimalresponsetoadefovirbasedcombination |